Technical Analysis for RGC - Regencell Bioscience Holdings Limited
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 3.21 | -4.46% | -0.15 |
RGC closed down 4.46 percent on Monday, July 1, 2024, on 21 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | -4.46% | |
| Wide Bands | Range Expansion | -4.46% | |
| Oversold Stochastic | Weakness | -4.46% |
| Alert | Time |
|---|---|
| Down 5% | about 7 hours ago |
| Down 3% | about 7 hours ago |
| Fell Below Lower Bollinger Band | about 7 hours ago |
| Fell Below Previous Day's Low | about 7 hours ago |
| Down 2 % | about 7 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Regencell Bioscience Holdings Limited operates a traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Neuroscience Psychiatric Diagnosis Psychiatry Attention Deficit Hyperactivity Disorder Autism Spectrum Disorder Traditional Chinese Medicine Autism Learning Disabilities Causeway Bay Neurocognition
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Neuroscience Psychiatric Diagnosis Psychiatry Attention Deficit Hyperactivity Disorder Autism Spectrum Disorder Traditional Chinese Medicine Autism Learning Disabilities Causeway Bay Neurocognition
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 30.49 |
| 52 Week Low | 3.13 |
| Average Volume | 2,304 |
| 200-Day Moving Average | 9.28 |
| 50-Day Moving Average | 4.87 |
| 20-Day Moving Average | 4.17 |
| 10-Day Moving Average | 3.71 |
| Average True Range | 0.31 |
| RSI (14) | 31.03 |
| ADX | 29.06 |
| +DI | 14.93 |
| -DI | 49.12 |
| Chandelier Exit (Long, 3 ATRs) | 4.08 |
| Chandelier Exit (Short, 3 ATRs) | 4.06 |
| Upper Bollinger Bands | 5.21 |
| Lower Bollinger Band | 3.14 |
| Percent B (%b) | 0.03 |
| BandWidth | 49.58 |
| MACD Line | -0.43 |
| MACD Signal Line | -0.34 |
| MACD Histogram | -0.0918 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.47 | ||||
| Resistance 3 (R3) | 3.47 | 3.38 | 3.42 | ||
| Resistance 2 (R2) | 3.38 | 3.32 | 3.38 | 3.41 | |
| Resistance 1 (R1) | 3.30 | 3.28 | 3.34 | 3.30 | 3.39 |
| Pivot Point | 3.21 | 3.21 | 3.24 | 3.21 | 3.21 |
| Support 1 (S1) | 3.13 | 3.15 | 3.17 | 3.13 | 3.03 |
| Support 2 (S2) | 3.04 | 3.11 | 3.04 | 3.01 | |
| Support 3 (S3) | 2.96 | 3.04 | 3.00 | ||
| Support 4 (S4) | 2.96 |
